Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Humacyte, Inc. - Common Stock (NQ: HUMA ) 5.080 +0.570 (+12.64%) Streaming Delayed Price Updated: 12:55 PM EST, Dec 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 7,615,316 Open 4.500 Bid (Size) 5.080 (12) Ask (Size) 5.090 (29) Prev. Close 4.510 Today's Range 4.400 - 5.250 52wk Range 2.480 - 9.970 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News HUMA Lead Plaintiff Deadline Approaching – Contact Robbins LLP for Information About the Class Action Against Humacyte, Inc. December 24, 2024 From Robbins LLP Via GlobeNewswire HUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the Firm December 23, 2024 From Bragar Eagel & Squire Via GlobeNewswire Performance YTD +75.78% +75.78% 1 Month +18.69% +18.69% 3 Month -6.87% -6.87% 6 Month +1.60% +1.60% 1 Year +74.57% +74.57% More News Read More Microsoft To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Monday December 23, 2024 Via Benzinga Spotlight on Humacyte: Analyzing the Surge in Options Activity December 20, 2024 Via Benzinga HUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Humacyte, Inc. Investors of Upcoming Deadline December 23, 2024 From Bernstein Liebhard LLP Via GlobeNewswire ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA December 20, 2024 From The Rosen Law Firm PA Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session December 20, 2024 Via Benzinga Dow Surges Over 600 Points, Gold Jumps 1.5% December 20, 2024 Via Benzinga Topics Stocks Exposures US Equities Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher December 20, 2024 Via Benzinga Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday December 20, 2024 Via Benzinga Why Is Bioengineered Human Tissue-Focused Humacyte Stock Surging On Friday? December 20, 2024 Via Benzinga Exposures Product Safety Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket December 20, 2024 Via Benzinga US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone' December 20, 2024 Via Benzinga HUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the Firm December 19, 2024 From Bragar Eagel & Squire Via GlobeNewswire DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte December 19, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire HUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Humacyte, Inc. Investors of Upcoming Deadline December 18, 2024 From Bernstein Liebhard LLP Via GlobeNewswire HUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the Firm December 17, 2024 From Bragar Eagel & Squire Via GlobeNewswire Investors who lost money on Humacyte, Inc.(HUMA) should contact Levi & Korsinsky about pending Class Action - HUMA December 17, 2024 Via ACCESSWIRE Humacyte, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 17, 2025 to Discuss Your Rights – HUMA December 16, 2024 Via ACCESSWIRE Shareholders that Lost Money on Humacyte, Inc. (HUMA) Should Contact Levi & Korsinsky about Pending Class Action - HUMA December 16, 2024 Via ACCESSWIRE Levi & Korsinsky Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025 - HUMA December 16, 2024 Via ACCESSWIRE The Schall Law Firm Encourages Shareholder Participation In A Securities Fraud Case Against Humacyte Inc December 16, 2024 Via ACCESSWIRE Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc. (HUMA) Shareholders December 16, 2024 Via ACCESSWIRE Class Action Filed Against Humacyte, Inc. (HUMA) Seeking Recovery for Investors - Contact Levi & Korsinsky December 16, 2024 Via ACCESSWIRE Humacyte, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - HUMA December 15, 2024 Via ACCESSWIRE Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
